IMNN · Imunon, Inc. · Investor Relations
$1.52
+0.07 (+4.82%)
At close · Sep 11
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Such conditions raise substantial doubts about the Company's ability to continue as a going concern. Based on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$8.14M
Shares
5.61M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-11 | Imunon Second Quarter 2026 Financial Results | Event |
| 2026-06-25 | Presentation at the Zacks SCR Life Sciences Virtual Investor Forum | Presentation |
| 2026-05-12 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-04-01 | Presentation at the MedInvest Biotech and Pharma Investor Conference | Conference |
| 2026-03-31 | Earnings conference call (announced in 8-K) | Earnings call |
Key facts
CIK
749647
CUSIP
15117N701
13F (30d)
17 filings
17 filers
Visit website
Investor relations